DeepHealth, TeraRecon announce collaboration around integrated AI and advanced visualization

American College of Radiology: “Americans shouldn’t forgo necessary, life-saving medical imaging”

The American College of Radiology released a statement in response to the recent paper, “Projected Lifetime Cancer Risks From Current Computed Tomography Imaging,” published in JAMA Internal Medicine.

April 18, 2025

Vol.51 No.15

How City of Hope is using AI to improve surgical outcomes

With recent leaps in artificial intelligence, there is major potential to turn computing advances into gains for human health.

University Hospitals Cleveland, Qure.ai collaborate on early lung cancer detection

University Hospitals Cleveland Medical Center has announced a collaboration with global healthcare AI company Qure.ai to deploy chest X-ray AI supporting earlier identification of lung cancers.

April 04, 2025

Vol.51 No.13

In Brief

Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application

Paradigm Health announced on March 20 the appointment of Karen E. Knudsen to its board of directors, alongside the upcoming launch of its eSource clinical trial data application.

March 28, 2025

Vol.51 No.12

Guest Editorial

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Technological innovations are often hailed as transformative tools capable of revolutionizing healthcare. From gene editing for conditions like sickle cell disease to AI predicting hospital readmissions, to telemedicine expanding healthcare access, these advancements have the potential to change the way we treat diseases.

March 21, 2025

Vol.51 No.11

By Jamillah Hoy-Rosas

Clinical Roundup

AI tool helps predict who will benefit from focal therapy for prostate cancer, study shows

A study led by UCLA investigators shows that AI could play a key role in improving treatment outcomes for patients with prostate cancer by helping physicians determine who is most likely to benefit from partial gland cryoablation, a minimally invasive procedure that treats localized prostate tumors.

March 21, 2025

Vol.51 No.11

DeepHealth, TeraRecon announce collaboration around integrated AI and advanced visualization

YOU MAY BE INTERESTED IN

American College of Radiology: “Americans shouldn’t forgo necessary, life-saving medical imaging”

How City of Hope is using AI to improve surgical outcomes

University Hospitals Cleveland, Qure.ai collaborate on early lung cancer detection

Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

AI tool helps predict who will benefit from focal therapy for prostate cancer, study shows

Renew today!

Subscriber content

Never miss an issue!

Login